Navigation Links
Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer
Date:6/24/2008

Summary: Genmab Initiates a Phase I/II Study of Zalutumumab in Combination With Radiotherapy for the Treatment of Advanced Head and Neck Cancer.

COPENHAGEN, June 24 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today it has initiated a Phase I/II study of zalutumumab (HuMax-EGFr(TM)) in combination with radiotherapy for the treatment of advanced head and neck cancer. The study will include a maximum of 36 patients who are ineligible for platinum based chemotherapy.

"Platinum based chemotherapy is currently considered to be the best available standard treatment for advanced head and neck cancer. We hope zalutumumab may some day provide a treatment option for patients who are in need of less toxic therapies," said Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab.

About the trial

In the dose-escalation part of the study, 6 to 24 patients will be enrolled in cohorts of 3 patients per dose level of zalutumumab. The dose level for each successive cohort will be determined by the aggregate safety data observed in the prior cohorts. When the maximum tolerated dose of zalutumumab is established, an additional cohort of 12 patients will be enrolled and treated at this level.

Patients in the study will receive 8 weekly infusions of zalutumumab with the first cohort receiving an initial dose of 12 mg/kg of zalutumumab followed by 7 maintenance doses of 8 mg/kg of zalutumumab in addition to radiotherapy. Patients will be evaluated at 4 weeks following the last dose of zalutumumab and will be followed for a total of 2 years.

The objective of the study is to evaluate the safety of repeat dosing and establish the maximum tolerated dose of zalutumumab in combination with radiotherapy in patients with advanced head and neck cancer who are ineligible for platinum based chemotherapy. The primary endpoint of the study is adverse events.

About Genmab A/S

Genmab is a leading international biotechnology co
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study
2. Genmab Announces Updates on Phase III Cancer Studies
3. Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
4. Bionomics Achieves US$1 Million Milestone Payment from Genmab
5. DAHANCA Initiates Head and Neck Cancer Study With Genmabs HuMax-EGFr
6. iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix
7. Peptimmune Initiates Phase Ib Study of PI-2301 in Multiple Sclerosis Patients and Presentation at BIO 2008
8. Transdel Initiates Ketotransdel(TM) Phase 3 Clinical Program for Pain
9. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
10. TorreyPines Therapeutics Initiates Clinical Trial to Evaluate Analgesic Effect of Oral Prodrug of Tezampanel
11. Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014  Jazz Pharmaceuticals plc (Nasdaq: ... its 2014 second quarter financial results on Tuesday, August ... Company management will host a live audio webcast immediately ... to provide a business and financial update and discuss ... may access the live audio webcast via the Investors ...
(Date:7/22/2014)... , July 22, 2014 Research ... "Cell Culture Market by Equipment, by Reagent, by ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... organisms. Cell culture is one of the most important ... also the largest application segment of the cell culture ...
(Date:7/22/2014)... 22, 2014 Legislation backed by the ... Local Pharmacies Act of 2014") championing so-called "any ... undermine the availability of lower cost preferred pharmacy ... over the next 10 years, according to new ... Pharmaceutical Care Management Association (PCMA). The ...
Breaking Medicine Technology:Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3New Study: H.R. 4577 to Cost $21 Billion over 10 Years 2New Study: H.R. 4577 to Cost $21 Billion over 10 Years 3
... 2011 West Pharmaceutical Services, Inc. (NYSE: WST ... investor conferences. Management will attend the 9th Annual ... NY.  Management will present an overview of West,s business and ... Management will also attend the UBS 2011 Global ...
... 2011 Prescription monitoring laboratory and clinical partner ... its Safe Use Treatment Monitoring Solution™. Consistent with ... compliant with the FDA,s Opioid Risk and Evaluation ... for controlled substances.  The program aims to support ...
Cached Medicine Technology:Dominion Diagnostics Leads Fight Against Prescription Drug Abuse with Safe Use Treatment Monitoring Solution 2
(Date:7/22/2014)... 22, 2014 As one alternative to ... to buy can now reduce or in some cases ... released its cosmetic buying guide to help buyers find ... http://cherrynews.com/best-nourishing-eye-serum . , This guide is meant for both ... different under eye circles that can appear. While some ...
(Date:7/22/2014)... Africa (PRWEB) July 23, 2014 It all ... in an attempt to find common ground. Willem de Liefde ... the crossroads of their lives or careers. , Willem wrote ... deeper and look beyond the surface of things. It is ... future, driven by care and commitment. , This book represents ...
(Date:7/22/2014)... Obtaining a bachelor’s degree in nursing ... have hands-on medical experience. The School of Nursing at ... the launch of an accelerated nursing degree program that ... program, the UNCG Veterans Access Program (VAP), will start ... With some prior college credit, veterans who are RNs ...
(Date:7/22/2014)... Dr. Dental is excited to announce the redesign ... in mind, one of the main differences from the old ... navigation very easy. Dr. Dental is renowned for having exceptional ... dentist affordable, convenient and fun, and the new website mirrors ... appointment scheduling system right on the home page where a ...
(Date:7/22/2014)... United Benefit Advisors (UBA), the nation's leading ... an insurance veteran with more than 15 years of ... based in the company's Chicago office. , UBA Board ... chose to accept this important, strategic position with UBA. ... challenges facing UBA and its Partners as we move ...
Breaking Medicine News(10 mins):Health News:Remove Dark Circles Under Eyes: New Cosmetic Buying Guide Released Online for Men and Women 2Health News:Willem de Liefde, Author and Management Expert, Releases New Guide for Understanding Friends, Family, Co-Workers and Ourselves 2Health News:UNCG School of Nursing Fast-Tracks Medically Trained Veterans 2Health News:Dr. Dental Reveals Exciting New Website 2Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 2Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 3Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 4Health News:Industry Leader Les McPhearson Joins United Benefit Advisors as New Chief Executive Officer 5
... Elbit Imaging Ltd.,(Nasdaq: EMITF ) ("EI" or ... of 2008., Loss for the first quarter of ... of which loss of NIS 27.3 million,(approximately US$ 7.7 ... while profit of NIS 23.8 million (approximately US$ 6.7,million) ...
... May 29 Subjects with type 1 or ... more frequently and,use the results to adjust treatment ... collection of state-of-the-art reports that,comprise a Special Supplement ... of Diabetes Technology & Therapeutics, a peer-reviewed journal ...
... New research from the Oregon Health & Science ... a wellspring of hope to many patients. , Researchers ... DNA abnormalities that can occur in a gene called ... kinds of acral and mucosal melanomas, which are less ...
... by Tel Aviv University researcher Prof. Illana Gozes may ... disease. This compound could also treat a number of ... schizophrenia and Parkinson,s, by limiting damage to the brain. ... found to protect American patients with mild cognitive damage ...
... bacteria break their metabolic processes into chunks. That may ... have now figured out the factors that tend to ... Santa Fe Institute and Stanford University, together with Anat ... University, constructed the metabolic networks of many species of ...
... used to prepare a powerful cancer-killing agent may be ... the natural product attacks, according to findings published in ... Chemistry. , Building on their earlier research into neocarzinostatin, ... University of Wisconsin, Madison discovered that one of the ...
Cached Medicine News:Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 2Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 3Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 4Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 5Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 6Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 7Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 8Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 9Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 10Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 11Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 12Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 13Health News:Self-Monitoring of Blood Glucose Highly Effective in Diabetes Care, According to a Special Issue of Diabetes Technology and Therapeutics 2Health News:Self-Monitoring of Blood Glucose Highly Effective in Diabetes Care, According to a Special Issue of Diabetes Technology and Therapeutics 3Health News:OHSU Cancer Instutute researchers find abnormalities in gene for melanoma 2Health News:Appealing the death sentence for brain cells 2Health News:Enzyme may hold key to improved targeting of cancer-fighting drugs 2
... Rail clamp with self-adjusting adaptability to ... permits complete versatility of angling at the ... The 3/D Swinger permits it to be ... With the Iron Intern®, a simple adjustment ...
Stainless steel construction to withstand sterilization modalities (EtO) Wide angle of view...
Inquire...
Inquire...
Medicine Products: